Business of Discovery Logo
google-plus2 facebook < /path> twitter blogger tumblr2 reddit linkedin delicious stumbleupon mail
Nearly a quarter of ISSCR members say they want to start a business. We gathered the experts to answer threshold questions: where to start, or if you should start at all.

Tuesday, 23 June 2020

Join us for a three-part workshop on the business end of science. You'll meet with entrepreneurs, investors and business leaders as we explore the many paths from lab bench to market – where to start, or if you should start at all.

The full-day program will host panel discussions on building a business model and pitch, attracting investment, and real stories from the people doing it.

Investigational therapies, new tools, and promising technologies are quickly advancing in stem cell science and regenerative medicine. In step, more than 20 percent of ISSCR members surveyed indicate near-term plans to start a business or an interest in doing so. This workshop is designed for you.


Location: ISSCR 2020 VIRTUAL
Date: 23 June, 2020 
Time: 10:30 — 17:30 EDT 
Registration: Included with ISSCR 2020 VIRTUAL Annual Meeting registration.

New business starts here.



Speakers + Topics

Topic 1 | The Pitch. The Plan.

10:30-12:00 EDT | 23 June

[ Starting a business in stem cell research and regenerative medicine comes with its own set of threshold questions, challenges, and considerations. Explore the elements of a successful pitch and business plan unique to this space. ]

Brock Reeve

[Program Committee + Session Chair]

Brock Reeve, MPhil, MBA

Executive Director
Harvard Stem Cell Institute


Andrea Armstrong, BA, MA
Chief Administrative Officer
Celsius Therapeutics


Christina Isacson, PhD
Chief Business Officer
Magenta Therapeutics


James Bradner, MD
Novartis Institutes for BioMedical Research


13:00-14:45 EDT | 23 June

[ Where to go, who to talk to, and what they'll be looking for. Hear from a spectrum of investors from incubator to Wall Street. ]

Stephen Freedman

[Program Committee + Session Chair]
Stephen Freedman, PhD

Vice President for Corporate Liaison and Ventures
Gladstone Institutes


Douglas Crawford, PhD
Managing Director, Mission Bay Capital
General Manager, MBC Biolabs


Ann DeWitt, PhD, MBA
General Partner, The Engine
Massachusetts Institute of Technology







Anjali Kumar, PhD
External Innovation Search and Evaluation, Johnson & Johnson Innovation

Matt McMahon

Matt McMahon, PhD
Director, SEED
NIH, Office of Extramural Research

Stories from the frontline

15:30-17:30 EDT | 23 June

[ Join entrepreneurs as they share their journeys from discovery to business. Hear their paths, approaches, and lessons learned. ]

Katherine High

[Program Committee + Session Chair]
Katherine A. High, MD

Co-Founder, Spark Therapeutics
Professor Emerita, Perelman School of Medicine at the University of Pennsylvania

Liu headshot - cropped_approved_resize

Tina Liu, MBA
Chief Executive Officer
Ally Therapeutics


Sarindr "Ik" Bhumiratana, PhD
Chief Scientific Officer & Co-Founder


Sangeeta Bhatia, MD, PhD
Massachusetts Institute of Technology &
Howard Hughes Medical Institute
Founder: Hepregen, Glympse Bio, Satellite Bio

Paul Tesar

[Program Committee + Session Chair]
Paul Tesar, PhD

Co-Founder, Convelo


Who Should Attend?

New, curious, or aspiring entrepreneurs interested in starting a business, moving discoveries from the bench to market.

How to Register

Register for ISSCR 2020 VIRTUAL. Participation in these sessions is included.